CheckMate 9LA: First-line nivolumab, ipilimumab and 2 cycles chemotherapy vs 4 cycles chemo in aNSCLC

CheckMate 816 trial: Nivolumab and platinum-doublet chemotherapy vs chemo as neoadjuvant treatment for resectable NSCLC

Phase III randomised trial comparing tebentafusp with investigator’s choice in first-line metastatic uveal melanoma

Randomised phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma

Healthy lifestyle may offset risk of lethal prostate cancer in men with high genetic risk

Oncoplastic breast surgery – real case examples from India

Which factors impact viewer satisfaction in educational videos?

SMMART Program: A multi-omics tumour board with a focus on breast cancer

PC14586: The first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development

Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma

Clinical validation of a targeted methylation-based multi-cancer early detection test

Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma